IXION BIOTECHNOLOGY INC
10QSB, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: IXION BIOTECHNOLOGY INC, 10QSB, 2000-08-14
Next: ADVANCED PLANT PHARMACEUTICALS INC, 10QSB, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>

     This schedule contains summary financial information extracted from
Financial Statements for the six months ended June 30, 2000, and is
qualified in its entirety by reference to such form 10QSB for quarterly period
ended June 30, 2000.
</LEGEND>

<MULTIPLIER>                                      1

<S>                                     <C>
<PERIOD-TYPE>                                 6-MOS
<FISCAL-YEAR-END>                       Dec-31-2000
<PERIOD-END>                            Jun-30-2000
<CASH>                                      240,292
<SECURITIES>                                      0
<RECEIVABLES>                                     9
<ALLOWANCES>                                      0
<INVENTORY>                                       0
<CURRENT-ASSETS>                            247,635
<PP&E>                                      131,540
<DEPRECIATION>                                    0
<TOTAL-ASSETS>                              780,366
<CURRENT-LIABILITIES>                      (595,959)
<BONDS>                                           0
<COMMON>                                    (32,158)
                             0
                                       0
<OTHER-SE>                                1,665,596
<TOTAL-LIABILITY-AND-EQUITY>               (780,366)
<SALES>                                           0
<TOTAL-REVENUES>                            133,220
<CGS>                                             0
<TOTAL-COSTS>                              (706,947)
<OTHER-EXPENSES>                                  0
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                          (87,478)
<INCOME-PRETAX>                            (573,727)
<INCOME-TAX>                                      0
<INCOME-CONTINUING>                        (573,727)
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                               (573,727)
<EPS-BASIC>                                  (.19)
<EPS-DILUTED>                                  (.19)







</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission